Page 115 - Traité de chimie thérapeutique 6 Médicaments antitumoraux
P. 115
4 MOUTARDES à L'AZOTE 71
BIBLIOGRAPHIE
BERGEL F., STOCK J.A., Melphalan, U.S. Patent 3,032,584, 1962.
LEDNICER D., MITSHER L.A., The Organic Chemistry of Drug Synthesis, John Wiley and
Sons, Inc., vol. 2, (1980), 120-121 et 299; ibid. vol. 3 (1984), 82-93.
FEYNS L.V., Melphalan, in Analytical Profiles ofDrug Substances, Florey K. ed, Academic
Press, Inc., 1984, vol. 13, 265-304.
TARIQ M., AL-SADR A., Chlorambucil, in Analytical Profiles of Drug Substances,
Florey K. ed., Academic Press, Inc., 1987, vol. 16, 85-118.
MARTY M. et al., Anticancéreux, in Pharmacologie Clinique; Bases de la Thérapeutique,
Giraud J.P., Expansion Scientifique Française, Paris, 1988, 1894-1958.
CALABRESI P., CHABNER B.A., Antineoplasic agents, in The Pharmacological Basis of
Therapeutics, Goodman Gilman A. ed., Pergamon Press, Inc., 1990, 8th ed., 1209-
1263.
PRATT W.B. et al., Sorne Milestones in the Development of Cancer Chemotherapy
(Ch. 2). in The Anticancer Drugs (2nd ed), Oxford University Press, 1994, 17-25;
108-122.
CRAUSE-MANCIET S. et al., Monographies, in Médicaments Anticancéreux, Husson
M.C., Becker A. (coord.), APHIF, Éditions Médicales Internationales, Cachan, 1995,
21-192.
TRANCHAND B., Guide Pratique de Pharmacocinétique Clinique en Oncologie, (2° éd.),
Editions Frison-Roche, Paris, 1997.
LEDNICER D., Strategies for Organic Drug Synthesis and Design, John Wiley and Sons,
Inc., 1998, 91-92.